Comparison of effects of cilnidipine and azelnidipine on blood pressure and urinary albumin excretion in type 2 diabetics with hypertension

Comparison of effects of cilnidipine and azelnidipine on blood pressure and urinary albumin excretion in type 2 diabetics with hypertension - Comparison of cilnidipine and azelnidipine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007201

Enrollment

Registered

2012-02-02

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetic patients

Interventions

cilnidipine azelnidipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetic patients with hypertension

Exclusion criteria

Exclusion criteria: Patients with severe renal or hepatic disease, overt cardiovascular disease, and malignancy were excluded

Design outcomes

Primary

Measure	Time frame
albuminuria	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026